Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Am J Prev Med. 2010 Jun;38(6):628-636.e1. doi: 10.1016/j.amepre.2010.03.003.
Very few studies have used community-based interventions for primary prevention of Type 2 diabetes, and the direct effect of such interventions on diabetes incidence is relatively unknown.
This study aims to assess the effect of lifestyle modification on risk factors for noncommunicable diseases (NCDs) and the development of Type 2 diabetes at the community level.
A cluster-controlled trial was conducted.
SETTING/PARTICIPANTS: In all, 3098 and 5114 individuals in intervention and control groups, respectively (mean age=43 years), recruited from District 13 of Tehran, Iran, participated in the baseline examination in 1999-2001. Among these individuals, a total of 1754 and 2993 individuals in the intervention and control groups, respectively (58%), completed a follow-up examination in 2002-2005.
The study intervention involved improvement in diet, increase in the level of physical activity, and reduction in cigarette smoking through educational interviews, lectures, and publications.
Incident Type 2 diabetes was measured by fasting plasma glucose (FPG) and 2-hour plasma glucose (2hPG) and change in NCD risk factors.
The mean follow-up time was 3.6 years. The incidence of diabetes in the control and intervention groups was 12.2 and 8.2 per 1000 person-years, respectively, with a relative risk reduction of 65% (95% CI=30%, 83%, p<0.003). The adjusted difference in mean change of risk factors between the intervention and control groups was significant for weight (-0.5 kg in men); BMI (-0.18 kg/m(2) in men); waist circumference (-1.0 cm in women); systolic and diastolic blood pressure (-1.1 and -0.6 mmHg, respectively, in women); FPG (-2.1 and -2.3 mg/dL in men and women); 2hPG (-4.6 mg/dL in women); total cholesterol (-2.8 mg/dL in women); triglycerides (-7.6 and -5.2 mg/dL in men and women); and high-density lipoprotein cholesterol (1.1 mg/dL in women; all p<0.05).
Lifestyle intervention resulted in a significant decrease in the incidence of Type 2 diabetes and better control of NCD risk factors in a population-based setting. ISRCTN TRIAL REGISTRATION #: ISRCTN52588395.
很少有研究使用基于社区的干预措施来预防 2 型糖尿病,这种干预措施对糖尿病发病率的直接影响还不太清楚。
本研究旨在评估生活方式改变对非传染性疾病(NCD)危险因素和社区 2 型糖尿病发病的影响。
这是一项整群对照试验。
地点/参与者:共有 3098 名和 5114 名分别来自伊朗德黑兰第 13 区的干预组和对照组的个体(平均年龄 43 岁),于 1999-2001 年参加了基线检查。其中,干预组和对照组分别有 1754 名和 2993 名个体(58%),于 2002-2005 年完成了随访检查。
研究干预措施包括通过教育访谈、讲座和出版物改善饮食、提高身体活动水平和减少吸烟。
通过空腹血糖(FPG)和 2 小时血糖(2hPG)测量和 NCD 危险因素的变化来衡量 2 型糖尿病的发病情况。
平均随访时间为 3.6 年。对照组和干预组的糖尿病发病率分别为 12.2 和 8.2/1000 人年,相对风险降低 65%(95%CI=30%,83%,p<0.003)。干预组和对照组之间的风险因素平均变化差异有统计学意义,包括体重(男性减少 0.5 公斤);BMI(男性减少 0.18kg/m2);腰围(女性减少 1.0 厘米);收缩压和舒张压(女性分别减少 1.1 和 0.6mmHg);FPG(男性和女性分别减少 2.1 和 2.3mg/dL);2hPG(女性减少 4.6mg/dL);总胆固醇(女性减少 2.8mg/dL);甘油三酯(男性和女性分别减少 7.6 和 5.2mg/dL);高密度脂蛋白胆固醇(女性增加 1.1mg/dL;所有 p<0.05)。
在基于人群的环境中,生活方式干预可显著降低 2 型糖尿病的发病率,并更好地控制非传染性疾病的危险因素。ISRCTN 临床试验注册编号:ISRCTN52588395。